| Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer A Ristimäki, A Sivula, J Lundin, M Lundin, T Salminen, C Haglund, ... Cancer research 62 (3), 632-635, 2002 | 1191 | 2002 |
| Deep learning based tissue analysis predicts outcome in colorectal cancer D Bychkov, N Linder, R Turkki, S Nordling, PE Kovanen, C Verrill, ... Scientific reports 8 (1), 3395, 2018 | 595 | 2018 |
| Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer B Sahu, M Laakso, K Ovaska, T Mirtti, J Lundin, A Rannikko, A Sankila, ... The EMBO journal 30 (19), 3962-3976, 2011 | 419 | 2011 |
| Amplification of erbB2 and erbB2 Expression Are Superior to Estrogen Receptor Status As Risk Factors for Distant Recurrence in pT1N0M0 Breast Cancer: A … H Joensuu, J Isola, M Lundin, T Salminen, K Holli, V Kataja, ... Clinical cancer research 9 (3), 923-930, 2003 | 301 | 2003 |
| Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study H Sihto, J Lundin, M Lundin, T Lehtimäki, A Ristimäki, K Holli, L Sailas, ... Breast Cancer Research 13, 1-11, 2011 | 265 | 2011 |
| Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma M Heinonen, P Bono, K Narko, SH Chang, J Lundin, H Joensuu, ... Cancer research 65 (6), 2157-2161, 2005 | 259 | 2005 |
| Risk for distant recurrence of breast cancer detected by mammography screening or other methods H Joensuu, T Lehtimäki, K Holli, L Elomaa, T Turpeenniemi-Hujanen, ... Jama 292 (9), 1064-1073, 2004 | 249 | 2004 |
| High LYVE-1–positive lymphatic vessel numbers are associated with poor outcome in breast cancer P Bono, VM Wasenius, P Heikkilä, J Lundin, DG Jackson, H Joensuu Clinical Cancer Research 10 (21), 7144-7149, 2004 | 248 | 2004 |
| Severe acute pancreatitis: prognostic factors in 270 consecutive patients KI Halonen, AK Leppäniemi, PA Puolakkainen, JE Lundin, ... Pancreas 21 (3), 266-271, 2000 | 235 | 2000 |
| Cleavable ErbB4 isoform in estrogen receptor–regulated growth of breast cancer cells TT Junttila, M Sundvall, M Lundin, J Lundin, M Tanner, P Härkönen, ... Cancer research 65 (4), 1384-1393, 2005 | 226 | 2005 |
| Artificial neural networks applied to survival prediction in breast cancer M Lundin, J Lundin, HB Burke, S Toikkanen, L Pylkkänen, H Joensuu Oncology 57 (4), 281-286, 1999 | 208 | 1999 |
| Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR J Mrena, JP Wiksten, A Thiel, A Kokkola, L Pohjola, J Lundin, S Nordling, ... Clinical Cancer Research 11 (20), 7362-7368, 2005 | 198 | 2005 |
| Phase I study with ONCOS-102 for the treatment of solid tumors–an evaluation of clinical response and exploratory analyses of immune markers T Ranki, S Pesonen, A Hemminki, K Partanen, K Kairemo, T Alanko, ... Journal for immunotherapy of cancer 4, 1-18, 2016 | 193 | 2016 |
| Identification of tumor epithelium and stroma in tissue microarrays using texture analysis N Linder, J Konsti, R Turkki, E Rahtu, M Lundin, S Nordling, C Haglund, ... Diagnostic pathology 7, 1-11, 2012 | 185 | 2012 |
| Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis S Blom, L Paavolainen, D Bychkov, R Turkki, P Mäki-Teeri, A Hemmes, ... Scientific reports 7 (1), 15580, 2017 | 152 | 2017 |
| Epithelial and stromal syndecan‐1 expression as predictor of outcome in patients with gastric cancer JP Wiksten, J Lundin, S Nordling, M Lundin, A Kokkola, ... International journal of cancer 95 (1), 1-6, 2001 | 152 | 2001 |
| Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer A Sivula, A Talvensaari-Mattila, J Lundin, H Joensuu, C Haglund, ... Breast cancer research and treatment 89, 215-220, 2005 | 149 | 2005 |
| The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer J Lundin, PJ Roberts, P Kuusela, C Haglund British journal of cancer 69 (3), 515-519, 1994 | 149 | 1994 |
| Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue V Häyry, LK Mäkinen, T Atula, H Sariola, A Mäkitie, I Leivo, H Keski-Säntti, ... British journal of cancer 102 (5), 892-897, 2010 | 143 | 2010 |
| Prognostic value of syndecan-1 expression in breast cancer M Leivonen, J Lundin, S Nordling, K Von Boguslawski, C Haglund Oncology 67 (1), 11-18, 2004 | 141 | 2004 |
Nina LinderMD, PhD, Adj Prof (Docent in molecular medicine), Inst for Molecular Medicine Finland, FIMM, UnivVerifierad e-postadress på helsinki.fi
